← Browse by Condition
Medical Condition

osteoporosis

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for osteoporosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteoporosis Clinical Trials

How many clinical trials are currently recruiting for osteoporosis?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for osteoporosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoporosis?
osteoporosis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoporosis clinical trial?
Eligibility criteria for osteoporosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
CHU de Quebec-Universite Laval 1 trial
Grigore T. Popa University of Medicine and Pharmacy 1 trial
AgNovos Healthcare, LLC 1 trial
Peter Humaidan 1 trial
S.LAB (SOLOWAYS) 1 trial

Recruiting Clinical Trials

NCT07067827
Recruiting
Self-questionnaire in Osteoporosis
Enrollment
58 pts
Location
Canada
Sponsor
CHU de Quebec-Universite Laval
View Trial →
NCT07141043
Recruiting
Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients
Enrollment
180 pts
Location
Romania
Sponsor
Grigore T. Popa University of ...
View Trial →
NCT05202678
Recruiting
RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis
Enrollment
150 pts
Location
Belgium
Sponsor
AgNovos Healthcare, LLC
View Trial →
NCT07546552
Recruiting
Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
Enrollment
100 pts
Location
Denmark
Sponsor
Peter Humaidan
View Trial →
NCT06867952
Recruiting
A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant
Enrollment
40 pts
Location
Russia
Sponsor
S.LAB (SOLOWAYS)
View Trial →
NCT06449742
Recruiting
A Prospective Observational Study of Artificial Intelligence Morphometric Evaluation of Vertebral Fractures
Enrollment
250 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT07412782
Recruiting
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Enrollment
100 pts
Location
Italy
Sponsor
Meyer Children's Hospital IRCC...
View Trial →
NCT07651306
Recruiting
Radiographic Cortical Thickness of the Humerus in Detecting Post-Stroke Regional Bone Loss
Enrollment
65 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Physical Medicine Reh...
View Trial →
NCT06059222 Phase 4
Recruiting
The Optimised Use of Romozosumab Study
Enrollment
270 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →

Related Conditions

osteopenia (2) hemodyalysis (1) kidney tansplant (1) ckd mbd chronic kidney disease mineral and bone disorder (1) female infertility (1) nf b ligand (1) rankl (1) follicle development (1) vertebral fracture (1) osteogenesis imperfecta (1) hypogonadisms (1) neoplasia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology